Home > Insider Trading > Filing (0001209191-12-054362)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337334	Steven Shak	301 Penobscot Drive Redwood City CA 94063	Evp Of R&D & Cmo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-11-20	4,701	$26.91	339,067	No	4	S	Direct
Common Stock	Disposition	2012-11-20	299	$27.43	338,768	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

This sale of common stock was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 8, 2012.
Represents weighted average sale price. Actual sale prices ranged from $26.38 to $27.37.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on each of February 15, 2013 and 2014, and the 1/3 of the shares that vested on February 15, 2012, net of withholding.
Includes 5,700 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014 and 1/3 of the shares on February 15, 2015.
Represents weighted average sale price. Actual sale prices ranged from $27.39 to $27.48.